▪ Company
▪ People
▪ News
▪ ESF grants
▪ Project portfolio
▪ Eureka
▪ Intellectual Property
▪ Services
▪ In Press
▪ Publications
▪ Thesises
▪ Cooperation
▪ Contact
▪ Estonian HealthTech Cluster

1)      Aints, A. Cell culture vessel. Useful model. Priority no 00 14/07PV, 3rd April 2007.

2)      Drews, M., Hunt, R., Voodla, K. The use of extract of selenium-enriched yeast (Se-YE) in mammalian cell culture media formulations. Priority no US61/059874, 9th June 2008.

3)      Lopp, M., Paju, A., Eek, M., Laos, M., Pehk, T., Jäälaid, R. Esters of (2-Hydroxy-3-oxo-cyclopent-1-enyl) acetic acid and method for preparation of (-)-R-homocitric acid γ-lactone, (+)-S-homocitric acid γ-lactone and the corresponding (-)-R-homocitric acid and (+)-S-homocitric acid salts from it. Priority no P200600017, 25th May 2007.

4)      Jõgi, A., Paju, A., Pehk, T., Siirde, K., Lopp, M. 4′-Aryl-2′,3′-dideoxynucleosides and their synthesis from 2-hydroxy-3-arylcyclopent-2-en-1-ones. Priority  no P200800040, 2nd June 2008.